SOMERSET, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced its technology-enabled revenue cycle management (RCM) and electronic health record (EHR) solutions have been reviewed by Business.com and recognized as the "Best Medical Software for Large Practices."
The healthcare industry is continually evolving, and medical practices are faced with the challenge of finding the right software solutions to enhance both clinical and administrative operations. In a crowded market, finding the most suitable software can be daunting. Medical practices require software that simplifies workflows, from appointment scheduling to patient encounters, as well as supports post-encounter tasks such as claims generation and denial management. CareCloud's solutions have proven to strike a perfect balance between comprehensiveness and user-friendliness.
Business.com conducted extensive research and evaluations of numerous medical software solutions, considering various aspects and features. After careful consideration, CareCloud emerged as the top choice for large practices. The evaluation criteria included factors like ease of use, pricing, implementation, training, mobile app accessibility, medical billing services, and more.
CareCloud's RCM and EHR solutions impressed the Business.com team with their user-friendly interfaces and comprehensive functionalities. The cloud-based platform offers integrated capabilities for EHR, patient experience management, and revenue cycle management, catering to more than 70 medical specialties. One notable feature is CareCloud Charts, which simplifies patient management, includes e-prescription functionality, and provides a comprehensive health summary view for patients, including medications and immunizations. Additionally, CareCloud's ability to manage all or part of a practice's revenue cycle, offering flexibility in choosing a practice management system, set it apart from competitors.
Among the strengths that led to CareCloud's recognition were:
"As a pioneer in healthcare technology solutions, our mission has been to equip healthcare practices and health systems with the essential tools not only to meet their specific needs but also to empower them to flourish within the ever-evolving healthcare landscape," affirmed Steve Link, chief operating officer of CareCloud. "With an impressive first-time pass rate of 97%, we take pride in our commitment to excellence. The recognition of our solutions as the 'Top Pick for Flexible Medical Billing' will undoubtedly bolster our efforts to connect with more clients, foster growth and continuously enhance our marketability."
To learn more about CareCloud’s comprehensive suite of technology-enabled services and solutions, visit carecloud.com/solutions.
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
Company Contact:
Bill Korn
Chief Strategy Officer
CareCloud
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$3.23 |
Daily Change: | 0.41 14.54 |
Daily Volume: | 1,917,225 |
Market Cap: | US$136.690M |
August 05, 2025 August 04, 2025 July 17, 2025 June 02, 2025 May 06, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load